Value & Access

Credibility is on the line when translating evidence on health interventions to value: from finding evidence gaps to conducting validation exercises of economic models, there is a wide range of tools to be used.

Defining and communicating the value of health interventions in light of the available data and methods should be done in a way that trust is being built. A quite few possible exercises are also available to find potential weakness of clinical and economic analyses, but identifying the right tool needs the expertise yielded by compiling more, than 50 full submission dossiers per annum.

Depending on the exact context of the submission dossier, our competence enables carrying out exercises such as, but not limited to:

• Validation exercises of economic models as a mean for the quality assurance of vendor deliverables;
• Critical appraisal of clinical and economic evidence to anticipate payer opposition and prepare for negotiations.
• Developing local adaptations of both clinical and economic analyses as well as filling evidence gaps with data coming from survey, interviews;
• Using RWD from the national-level retrospective database of the payer to support the available body of evidence;
• Conceptualising and development of models for the economic evaluation of medicinal products, medical devices, as well as public health interventions.